Form 483

Active Cosmetics Manufacturing Inc Form 483, 2018-10-18

FDA issued a Form 483 to Active Cosmetics Manufacturing Inc on 2018-10-18 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Active Cosmetics Manufacturing Inc · Orlando, United States · Issued October 18, 2018

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Oct 2018
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Saundrea A Munroe

18 Oct 2018
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Saundrea A Munroe

18 Oct 2018
21 CFR 211.165(a)

Testing and release for distribution

Cited by Saundrea A Munroe

18 Oct 2018
21 CFR 211.198(b)

Written complaint record to be maintained at facility

Cited by Saundrea A Munroe

18 Oct 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Saundrea A Munroe

Inspected site

ACActive Cosmetics Manufacturing IncOrlando, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere